Both 5 μg/mL and 50 μg/mL of nanaomycin K significantly inhibited KK47 and T24 cancer cell growth in the presence of TGF-β compared to controls after 72 h of culture (p < 0.01, or p < 0.01) (Fig. 1). The gene discussed is TGFB1; the disease is cancer.